CAS: 10340-91-7; Benzylisocyanide

该化合物是一种有机化合物,其特征是附于一个苯基组的异氰化物功能组,其典型特征是无色的黄色淡液,有独特的,不光彩的气味,该化合物因其活性而闻名于色,特别是核分裂生殖反应,因为异氰化物碳的电益性质.Benzyl 异氰化物在乙醚和氯仿等有机溶剂中溶解,但一般在水中溶解.该化合物用于各种合成用途,包括制作异氰化物的化合物,并用于热循环合成.此外,该化合物可以作为有机化学的建筑块,特别是在制药和农用化学的开发过程中.然而,必须小心处理异辛基苯基,因为它可能有毒,并且对皮肤和呼吸系统具有刺激作用.在实验室与该化合物打交道时,应采取适当的安全防范措施.

结构式图片

相似化合物

104-84-7 539-48-0 10406-25-4

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

silver(I) cyanide iodomethylbenzene chloroform benzylamine3-is°Cyano-3-phenyl-propan-1-ol 4-is°Cyano-4-phenyl-butan-1-ol 4-is°Cyano-3-methyl-4-phenyl-butan-2-ol H-[1,3]thiazine6-diethoxymethyl-4-phenyl-5,6-dihydro-4H-[1,3]thiazine

合成工艺路线路线简述

    N-Benzylthioformamide置于三乙胺,苯乙酰氯,N,N'-二异丙基碳二亚胺体系中,用 乙醚 用作溶剂,化学反应生成苄异腈
    参考文献:Hartke,K.,Chemische Berichte,1966,Vol. 99,P. 3163-3172
    标题:Hartke,K.,Chemische Berichte,1966,Vol. 99,P. 3163-3172

    专利信息


    专利号:US-6376649-B1
    优先权日:1998-12-18
    标题 :Methods for the synthesis of α- hydroxy-β-amino acid and amide derivatives
    发明人:SEMPLE JOSEPH E; LEVY ODILE E
    权利人:CORVAS INT INC
    摘要:Methods for the synthesis of alpha-hydroxy-beta-amino acid and amide derivatives and alpha-ketoamide derivatives and novel derivatives made by these methods are provided. These methods involve reacting a N-terminally blocked (protected) aminoaldehyde with an isonitrile and a carboxylic acid to give an amino-alpha-acyloxy carboxamide. The acyloxy group may be removed to give the derivative. Alternatively the protecting group is removed and acyl shift occurs to give the derivative. These derivatives are useful in the synthesis of compounds such as peptidyl alpha-ketoamides and alpha-hydroxy-beta-carboxylic acid and amide derivatives. Certain of these compounds have been reported to have activity as inhibitors of proteases, such as serine proteases and cysteine proteases.

    专利号:WO-2016122325-A1
    优先权日:2015-01-30
    标 题:Methods for providing intermediates in the synthesis of atorvastatin.
    发明人:DÖMLING ALEXANDER STEPHAN SIEGFRIED
    权利人:UNIV GRONINGEN
    摘要:The invention relates to the field of medicinal chemistry, In particular, it relates to methods for providing intermediates in the synthesis of Atorvastatin, a competitive inhibitor of HMG-Co A reductase. Provided is a process for providing a compound having a Formula (I) or a pharmaceutically acceptable salt, ester, amide or stereoisomer thereof, comprising reacting in a 4 component Ugi-reaction in a single reaction mixture the compounds of formula A, formula B, formula C and formula D.

    专利号:US-2017320908-A1
    优先权日:2014-11-19
    标题 :Solid phase synthesis of cyclic amino acid molecules
    发明人:HICKEY JENNIFER L; MANCUSO JOHN; MARSAULT ERIC; ROUGHTON ANDREW L; TREDER ADAM P; TREMBLEY MARIE-CLAUDE J; YUDIN ANDREI K; ZARETSKY SERGE
    权利人:ENCYCLE THERAPEUTICS; GOVERNING COUNCIL OF THE UNIV OF TORONTO; UNIV SHERBROOKE
    摘要:The present invention relates to cyclic amino acid molecules and methods of preparing the same, and in particular the macrocyclization of amino acids or linear peptides bound to a solid support.

    专利号:US-6225329-B1
    优先权日:1998-03-12
    标 题 :Modulators of protein tyrosine phosphatases (PTPases)
    发明人:RICHTER LUTZ STEFAN; ANDERSEN HENRIK SUNE; VAGNER JOSEF; JEPPESEN CLAUS BEKKER; MOELLER NIELS PETER HUNDAHL; BRANNER SVEN; SU JING; BAKIR FARID; JUDGE LUKE MILBURN
    权利人:NOVO NORDISK AS
    摘要:The present invention provides novel compounds of Formula 1, compositions containing these compounds, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPase's) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like, n wherein A, R 1 , R 2 , R 3 , R 4 , R 16 and R 17 are as defined in the specification. The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimer's disease and schizophrenia, and infectious diseases.

    专利号:US-2014296354-A1
    优先权日:2013-04-01
    标题 :Synthesis of peptoid-based small molecular gelators from multiple component reactions
    发明人:WANG GUIJUN; MANGUNURU HARI P R
    权利人:WANG GUIJUN; MANGUNURU HARI P R; OLD DOMINION UNIV RES FOUND
    摘要:Described herein are the one-pot synthesis and characterization of a library of low molecular weight peptoid compounds that are able to form gels at room temperature. The compounds are synthesized from biologically-based starting materials, are biocompatible, and are resistant to degradation by proteases and peptidases. The compounds and gels synthesized therefrom can be used in such applications as tissue engineering, drug delivery, separation of biomolecules, and stimulus-responsive advanced materials

    专利号:WO-9946236-A1
    优先权日:1998-03-12
    标题 :Modulators of protein tyrosine phosphatases (ptpases)
    发明人:RICHTER LUTZ STEFAN; ANDERSEN HENRIK SUNE; VAGNER JOSEF; JEPPESEN CLAUS BEKKER; MOELLER NIELS PETER HUNDAHL; BRANNER SVEN; SU JING; BAKIR FARID; JUDGE LUKE MILBURN
    权利人:NOVO NORDISK AS; ONTOGEN CORP
    摘要:The present invention provides novel compounds, novel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPases) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like. The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimer's disease and schizophrenia, and infectious diseases.
    嘉兴市吉拉特化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jlightchem.com
    企业联系电话:0573-82813637;82813639👤
    📞嘉兴市吉拉特化工有限公司 ⚠️参考联系方式
    联系人:魏经理;王经理;叶经理
    电话:0573-82813637;82813639
    手机:13605839392;15857374971;15157377625
    传真:0573-82813637
    邮箱:sales@jlightchem.com
    通信地址: 浙江省嘉兴市大桥镇嘉兴工业园区东塘支路北侧
    邮编: 314006
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省嘉兴市大桥镇嘉兴工业园区东塘支路北侧
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Laurent El Kam, Et Al. Smiles Rearrangements In Ugi- And Passerini-Type Couplings: New Multicomponent Access To O- And N-Arylamides. J Org Chem. 2007 May 25;72(11):4169-80.

    合成参考文献


    参考文献:10.1107/s160053681100821x
    摘要:Nichol GS, Sharma A, Li H. N,N′-Bis(5-bromopyridin-2-yl)methanediamine. Acta Crystallogr E Struct Rep Online. 2011 Mar 09;67(4):o833. doi: 10.1107/s160053681100821x.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知